ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In Vivo Pharmacology Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-4T12194
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global In Vivo Pharmacology Market Research Report 2022
BUY CHAPTERS

Global In Vivo Pharmacology Market Research Report 2025

Code: QYRE-Auto-4T12194
Report
February 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
The Jackson Laboratory
Evotec AG
Pharmaron
Aurigene Pharmaceutical
Jubilant Biosys
LabCorp
Inotiv, Inc.
Takeda Pharmaceutical
Novartis
Sygnature Discovery
GenScript ProBio
ZAI LAB
Eli Lilly
EXUMA Biotech
Be Biopharma
Alderley Oncology
Sinclair Research
Gubra
Syngene
Charles River

In Vivo Pharmacology Market Size

The global market for In Vivo Pharmacology was valued at US$ 4363 million in the year 2024 and is projected to reach a revised size of US$ 6397 million by 2031, growing at a CAGR of 5.7% during the forecast period.

In Vivo Pharmacology Market

In Vivo Pharmacology Market

In vivo pharmacology is a branch of pharmacology that focuses on the study of the effects, mechanisms of action, and safety of drugs and pharmaceutical compounds within living organisms. This field involves conducting experiments and tests on whole living organisms, such as animals (commonly rodents like mice and rats) and, in some cases, humans, to assess the pharmacological properties of drugs. In vivo studies are essential for understanding how drugs interact with biological systems, including their absorption, distribution, metabolism, and excretion (ADME), as well as their therapeutic effects and potential side effects.
Increasing Drug Development Activities: The pharmaceutical and biotechnology industries continue to expand, leading to increased demand for in vivo pharmacology services. Companies are actively developing new drugs, including those for complex diseases like cancer, autoimmune disorders, and neurodegenerative conditions, which often require extensive preclinical testing.
Increased Regulatory Scrutiny: Regulatory agencies, like the U.S. FDA and the European Medicines Agency, are continuously raising the bar for drug safety and efficacy. This has led to stricter requirements for preclinical testing, including more comprehensive and sophisticated in vivo studies.
Advancements in Animal Models: The development of more sophisticated and relevant animal models, including genetically engineered mice and patient-derived xenograft models, has enhanced the accuracy and predictive value of in vivo pharmacology studies.
Outsourcing and CRO Services: Many pharmaceutical companies are outsourcing their in vivo pharmacology studies to contract research organizations (CROs) to gain cost-efficiency, access specialized expertise, and meet timelines. This trend is expected to continue.
This report aims to provide a comprehensive presentation of the global market for In Vivo Pharmacology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo Pharmacology.
The In Vivo Pharmacology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vivo Pharmacology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vivo Pharmacology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of In Vivo Pharmacology Market Report

Report Metric Details
Report Name In Vivo Pharmacology Market
Accounted market size in year US$ 4363 million
Forecasted market size in 2031 US$ 6397 million
CAGR 5.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Animal Disease Models
  • Ex Vivo Pharmacology & Biomarkers
  • PD/PK
  • Others
Segment by Application
  • Ncology/Immuno-oncology
  • Metabolic Disorders
  • Inflammatory Diseases
  • CNS Diseases
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, The Jackson Laboratory, Syngene, Evotec, Pharmaron, Aurigene Pharmaceutical, Jubilant Biosys, Labcorp, Inotiv, Takeda Pharmaceutical, EXUMA Biotech, Novartis, Be Biopharma, Alderley Oncology, Sygnature Discovery, GenScript ProBio, Zai Lab, Sinclair Research, Eli Lilly, Gubra
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of In Vivo Pharmacology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is In Vivo Pharmacology Market growing?

Ans: The In Vivo Pharmacology Market witnessing a CAGR of 5.7% during the forecast period 2025-2031.

What is the In Vivo Pharmacology Market size in 2031?

Ans: The In Vivo Pharmacology Market size in 2031 will be US$ 6397 million.

Who are the main players in the In Vivo Pharmacology Market report?

Ans: The main players in the In Vivo Pharmacology Market are Charles River, The Jackson Laboratory, Syngene, Evotec, Pharmaron, Aurigene Pharmaceutical, Jubilant Biosys, Labcorp, Inotiv, Takeda Pharmaceutical, EXUMA Biotech, Novartis, Be Biopharma, Alderley Oncology, Sygnature Discovery, GenScript ProBio, Zai Lab, Sinclair Research, Eli Lilly, Gubra

What are the Application segmentation covered in the In Vivo Pharmacology Market report?

Ans: The Applications covered in the In Vivo Pharmacology Market report are Ncology/Immuno-oncology, Metabolic Disorders, Inflammatory Diseases, CNS Diseases

What are the Type segmentation covered in the In Vivo Pharmacology Market report?

Ans: The Types covered in the In Vivo Pharmacology Market report are Animal Disease Models, Ex Vivo Pharmacology & Biomarkers, PD/PK, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vivo Pharmacology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Animal Disease Models
1.2.3 Ex Vivo Pharmacology & Biomarkers
1.2.4 PD/PK
1.2.5 Others
1.3 Market by Application
1.3.1 Global In Vivo Pharmacology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Ncology/Immuno-oncology
1.3.3 Metabolic Disorders
1.3.4 Inflammatory Diseases
1.3.5 CNS Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vivo Pharmacology Market Perspective (2020-2031)
2.2 Global In Vivo Pharmacology Growth Trends by Region
2.2.1 Global In Vivo Pharmacology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vivo Pharmacology Historic Market Size by Region (2020-2025)
2.2.3 In Vivo Pharmacology Forecasted Market Size by Region (2026-2031)
2.3 In Vivo Pharmacology Market Dynamics
2.3.1 In Vivo Pharmacology Industry Trends
2.3.2 In Vivo Pharmacology Market Drivers
2.3.3 In Vivo Pharmacology Market Challenges
2.3.4 In Vivo Pharmacology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vivo Pharmacology Players by Revenue
3.1.1 Global Top In Vivo Pharmacology Players by Revenue (2020-2025)
3.1.2 Global In Vivo Pharmacology Revenue Market Share by Players (2020-2025)
3.2 Global In Vivo Pharmacology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vivo Pharmacology Revenue
3.4 Global In Vivo Pharmacology Market Concentration Ratio
3.4.1 Global In Vivo Pharmacology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vivo Pharmacology Revenue in 2024
3.5 Global Key Players of In Vivo Pharmacology Head office and Area Served
3.6 Global Key Players of In Vivo Pharmacology, Product and Application
3.7 Global Key Players of In Vivo Pharmacology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vivo Pharmacology Breakdown Data by Type
4.1 Global In Vivo Pharmacology Historic Market Size by Type (2020-2025)
4.2 Global In Vivo Pharmacology Forecasted Market Size by Type (2026-2031)
5 In Vivo Pharmacology Breakdown Data by Application
5.1 Global In Vivo Pharmacology Historic Market Size by Application (2020-2025)
5.2 Global In Vivo Pharmacology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vivo Pharmacology Market Size (2020-2031)
6.2 North America In Vivo Pharmacology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vivo Pharmacology Market Size by Country (2020-2025)
6.4 North America In Vivo Pharmacology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vivo Pharmacology Market Size (2020-2031)
7.2 Europe In Vivo Pharmacology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vivo Pharmacology Market Size by Country (2020-2025)
7.4 Europe In Vivo Pharmacology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vivo Pharmacology Market Size (2020-2031)
8.2 Asia-Pacific In Vivo Pharmacology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vivo Pharmacology Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vivo Pharmacology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vivo Pharmacology Market Size (2020-2031)
9.2 Latin America In Vivo Pharmacology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vivo Pharmacology Market Size by Country (2020-2025)
9.4 Latin America In Vivo Pharmacology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vivo Pharmacology Market Size (2020-2031)
10.2 Middle East & Africa In Vivo Pharmacology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vivo Pharmacology Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vivo Pharmacology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River In Vivo Pharmacology Introduction
11.1.4 Charles River Revenue in In Vivo Pharmacology Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 The Jackson Laboratory
11.2.1 The Jackson Laboratory Company Details
11.2.2 The Jackson Laboratory Business Overview
11.2.3 The Jackson Laboratory In Vivo Pharmacology Introduction
11.2.4 The Jackson Laboratory Revenue in In Vivo Pharmacology Business (2020-2025)
11.2.5 The Jackson Laboratory Recent Development
11.3 Syngene
11.3.1 Syngene Company Details
11.3.2 Syngene Business Overview
11.3.3 Syngene In Vivo Pharmacology Introduction
11.3.4 Syngene Revenue in In Vivo Pharmacology Business (2020-2025)
11.3.5 Syngene Recent Development
11.4 Evotec
11.4.1 Evotec Company Details
11.4.2 Evotec Business Overview
11.4.3 Evotec In Vivo Pharmacology Introduction
11.4.4 Evotec Revenue in In Vivo Pharmacology Business (2020-2025)
11.4.5 Evotec Recent Development
11.5 Pharmaron
11.5.1 Pharmaron Company Details
11.5.2 Pharmaron Business Overview
11.5.3 Pharmaron In Vivo Pharmacology Introduction
11.5.4 Pharmaron Revenue in In Vivo Pharmacology Business (2020-2025)
11.5.5 Pharmaron Recent Development
11.6 Aurigene Pharmaceutical
11.6.1 Aurigene Pharmaceutical Company Details
11.6.2 Aurigene Pharmaceutical Business Overview
11.6.3 Aurigene Pharmaceutical In Vivo Pharmacology Introduction
11.6.4 Aurigene Pharmaceutical Revenue in In Vivo Pharmacology Business (2020-2025)
11.6.5 Aurigene Pharmaceutical Recent Development
11.7 Jubilant Biosys
11.7.1 Jubilant Biosys Company Details
11.7.2 Jubilant Biosys Business Overview
11.7.3 Jubilant Biosys In Vivo Pharmacology Introduction
11.7.4 Jubilant Biosys Revenue in In Vivo Pharmacology Business (2020-2025)
11.7.5 Jubilant Biosys Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Details
11.8.2 Labcorp Business Overview
11.8.3 Labcorp In Vivo Pharmacology Introduction
11.8.4 Labcorp Revenue in In Vivo Pharmacology Business (2020-2025)
11.8.5 Labcorp Recent Development
11.9 Inotiv
11.9.1 Inotiv Company Details
11.9.2 Inotiv Business Overview
11.9.3 Inotiv In Vivo Pharmacology Introduction
11.9.4 Inotiv Revenue in In Vivo Pharmacology Business (2020-2025)
11.9.5 Inotiv Recent Development
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Company Details
11.10.2 Takeda Pharmaceutical Business Overview
11.10.3 Takeda Pharmaceutical In Vivo Pharmacology Introduction
11.10.4 Takeda Pharmaceutical Revenue in In Vivo Pharmacology Business (2020-2025)
11.10.5 Takeda Pharmaceutical Recent Development
11.11 EXUMA Biotech
11.11.1 EXUMA Biotech Company Details
11.11.2 EXUMA Biotech Business Overview
11.11.3 EXUMA Biotech In Vivo Pharmacology Introduction
11.11.4 EXUMA Biotech Revenue in In Vivo Pharmacology Business (2020-2025)
11.11.5 EXUMA Biotech Recent Development
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis In Vivo Pharmacology Introduction
11.12.4 Novartis Revenue in In Vivo Pharmacology Business (2020-2025)
11.12.5 Novartis Recent Development
11.13 Be Biopharma
11.13.1 Be Biopharma Company Details
11.13.2 Be Biopharma Business Overview
11.13.3 Be Biopharma In Vivo Pharmacology Introduction
11.13.4 Be Biopharma Revenue in In Vivo Pharmacology Business (2020-2025)
11.13.5 Be Biopharma Recent Development
11.14 Alderley Oncology
11.14.1 Alderley Oncology Company Details
11.14.2 Alderley Oncology Business Overview
11.14.3 Alderley Oncology In Vivo Pharmacology Introduction
11.14.4 Alderley Oncology Revenue in In Vivo Pharmacology Business (2020-2025)
11.14.5 Alderley Oncology Recent Development
11.15 Sygnature Discovery
11.15.1 Sygnature Discovery Company Details
11.15.2 Sygnature Discovery Business Overview
11.15.3 Sygnature Discovery In Vivo Pharmacology Introduction
11.15.4 Sygnature Discovery Revenue in In Vivo Pharmacology Business (2020-2025)
11.15.5 Sygnature Discovery Recent Development
11.16 GenScript ProBio
11.16.1 GenScript ProBio Company Details
11.16.2 GenScript ProBio Business Overview
11.16.3 GenScript ProBio In Vivo Pharmacology Introduction
11.16.4 GenScript ProBio Revenue in In Vivo Pharmacology Business (2020-2025)
11.16.5 GenScript ProBio Recent Development
11.17 Zai Lab
11.17.1 Zai Lab Company Details
11.17.2 Zai Lab Business Overview
11.17.3 Zai Lab In Vivo Pharmacology Introduction
11.17.4 Zai Lab Revenue in In Vivo Pharmacology Business (2020-2025)
11.17.5 Zai Lab Recent Development
11.18 Sinclair Research
11.18.1 Sinclair Research Company Details
11.18.2 Sinclair Research Business Overview
11.18.3 Sinclair Research In Vivo Pharmacology Introduction
11.18.4 Sinclair Research Revenue in In Vivo Pharmacology Business (2020-2025)
11.18.5 Sinclair Research Recent Development
11.19 Eli Lilly
11.19.1 Eli Lilly Company Details
11.19.2 Eli Lilly Business Overview
11.19.3 Eli Lilly In Vivo Pharmacology Introduction
11.19.4 Eli Lilly Revenue in In Vivo Pharmacology Business (2020-2025)
11.19.5 Eli Lilly Recent Development
11.20 Gubra
11.20.1 Gubra Company Details
11.20.2 Gubra Business Overview
11.20.3 Gubra In Vivo Pharmacology Introduction
11.20.4 Gubra Revenue in In Vivo Pharmacology Business (2020-2025)
11.20.5 Gubra Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
The Jackson Laboratory
Evotec AG
Pharmaron
Aurigene Pharmaceutical
Jubilant Biosys
LabCorp
Inotiv, Inc.
Takeda Pharmaceutical
Novartis
Sygnature Discovery
GenScript ProBio
ZAI LAB
Eli Lilly
EXUMA Biotech
Be Biopharma
Alderley Oncology
Sinclair Research
Gubra
Syngene
Charles River
List of Tables
 Table 1. Global In Vivo Pharmacology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Animal Disease Models
 Table 3. Key Players of Ex Vivo Pharmacology & Biomarkers
 Table 4. Key Players of PD/PK
 Table 5. Key Players of Others
 Table 6. Global In Vivo Pharmacology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global In Vivo Pharmacology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global In Vivo Pharmacology Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global In Vivo Pharmacology Market Share by Region (2020-2025)
 Table 10. Global In Vivo Pharmacology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global In Vivo Pharmacology Market Share by Region (2026-2031)
 Table 12. In Vivo Pharmacology Market Trends
 Table 13. In Vivo Pharmacology Market Drivers
 Table 14. In Vivo Pharmacology Market Challenges
 Table 15. In Vivo Pharmacology Market Restraints
 Table 16. Global In Vivo Pharmacology Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global In Vivo Pharmacology Market Share by Players (2020-2025)
 Table 18. Global Top In Vivo Pharmacology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Pharmacology as of 2024)
 Table 19. Ranking of Global Top In Vivo Pharmacology Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by In Vivo Pharmacology Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of In Vivo Pharmacology, Headquarters and Area Served
 Table 22. Global Key Players of In Vivo Pharmacology, Product and Application
 Table 23. Global Key Players of In Vivo Pharmacology, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global In Vivo Pharmacology Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global In Vivo Pharmacology Revenue Market Share by Type (2020-2025)
 Table 27. Global In Vivo Pharmacology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global In Vivo Pharmacology Revenue Market Share by Type (2026-2031)
 Table 29. Global In Vivo Pharmacology Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global In Vivo Pharmacology Revenue Market Share by Application (2020-2025)
 Table 31. Global In Vivo Pharmacology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global In Vivo Pharmacology Revenue Market Share by Application (2026-2031)
 Table 33. North America In Vivo Pharmacology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America In Vivo Pharmacology Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America In Vivo Pharmacology Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe In Vivo Pharmacology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe In Vivo Pharmacology Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe In Vivo Pharmacology Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific In Vivo Pharmacology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific In Vivo Pharmacology Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific In Vivo Pharmacology Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America In Vivo Pharmacology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America In Vivo Pharmacology Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America In Vivo Pharmacology Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa In Vivo Pharmacology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa In Vivo Pharmacology Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa In Vivo Pharmacology Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Charles River Company Details
 Table 49. Charles River Business Overview
 Table 50. Charles River In Vivo Pharmacology Product
 Table 51. Charles River Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 52. Charles River Recent Development
 Table 53. The Jackson Laboratory Company Details
 Table 54. The Jackson Laboratory Business Overview
 Table 55. The Jackson Laboratory In Vivo Pharmacology Product
 Table 56. The Jackson Laboratory Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 57. The Jackson Laboratory Recent Development
 Table 58. Syngene Company Details
 Table 59. Syngene Business Overview
 Table 60. Syngene In Vivo Pharmacology Product
 Table 61. Syngene Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 62. Syngene Recent Development
 Table 63. Evotec Company Details
 Table 64. Evotec Business Overview
 Table 65. Evotec In Vivo Pharmacology Product
 Table 66. Evotec Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 67. Evotec Recent Development
 Table 68. Pharmaron Company Details
 Table 69. Pharmaron Business Overview
 Table 70. Pharmaron In Vivo Pharmacology Product
 Table 71. Pharmaron Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 72. Pharmaron Recent Development
 Table 73. Aurigene Pharmaceutical Company Details
 Table 74. Aurigene Pharmaceutical Business Overview
 Table 75. Aurigene Pharmaceutical In Vivo Pharmacology Product
 Table 76. Aurigene Pharmaceutical Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 77. Aurigene Pharmaceutical Recent Development
 Table 78. Jubilant Biosys Company Details
 Table 79. Jubilant Biosys Business Overview
 Table 80. Jubilant Biosys In Vivo Pharmacology Product
 Table 81. Jubilant Biosys Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 82. Jubilant Biosys Recent Development
 Table 83. Labcorp Company Details
 Table 84. Labcorp Business Overview
 Table 85. Labcorp In Vivo Pharmacology Product
 Table 86. Labcorp Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 87. Labcorp Recent Development
 Table 88. Inotiv Company Details
 Table 89. Inotiv Business Overview
 Table 90. Inotiv In Vivo Pharmacology Product
 Table 91. Inotiv Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 92. Inotiv Recent Development
 Table 93. Takeda Pharmaceutical Company Details
 Table 94. Takeda Pharmaceutical Business Overview
 Table 95. Takeda Pharmaceutical In Vivo Pharmacology Product
 Table 96. Takeda Pharmaceutical Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 97. Takeda Pharmaceutical Recent Development
 Table 98. EXUMA Biotech Company Details
 Table 99. EXUMA Biotech Business Overview
 Table 100. EXUMA Biotech In Vivo Pharmacology Product
 Table 101. EXUMA Biotech Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 102. EXUMA Biotech Recent Development
 Table 103. Novartis Company Details
 Table 104. Novartis Business Overview
 Table 105. Novartis In Vivo Pharmacology Product
 Table 106. Novartis Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 107. Novartis Recent Development
 Table 108. Be Biopharma Company Details
 Table 109. Be Biopharma Business Overview
 Table 110. Be Biopharma In Vivo Pharmacology Product
 Table 111. Be Biopharma Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 112. Be Biopharma Recent Development
 Table 113. Alderley Oncology Company Details
 Table 114. Alderley Oncology Business Overview
 Table 115. Alderley Oncology In Vivo Pharmacology Product
 Table 116. Alderley Oncology Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 117. Alderley Oncology Recent Development
 Table 118. Sygnature Discovery Company Details
 Table 119. Sygnature Discovery Business Overview
 Table 120. Sygnature Discovery In Vivo Pharmacology Product
 Table 121. Sygnature Discovery Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 122. Sygnature Discovery Recent Development
 Table 123. GenScript ProBio Company Details
 Table 124. GenScript ProBio Business Overview
 Table 125. GenScript ProBio In Vivo Pharmacology Product
 Table 126. GenScript ProBio Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 127. GenScript ProBio Recent Development
 Table 128. Zai Lab Company Details
 Table 129. Zai Lab Business Overview
 Table 130. Zai Lab In Vivo Pharmacology Product
 Table 131. Zai Lab Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 132. Zai Lab Recent Development
 Table 133. Sinclair Research Company Details
 Table 134. Sinclair Research Business Overview
 Table 135. Sinclair Research In Vivo Pharmacology Product
 Table 136. Sinclair Research Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 137. Sinclair Research Recent Development
 Table 138. Eli Lilly Company Details
 Table 139. Eli Lilly Business Overview
 Table 140. Eli Lilly In Vivo Pharmacology Product
 Table 141. Eli Lilly Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 142. Eli Lilly Recent Development
 Table 143. Gubra Company Details
 Table 144. Gubra Business Overview
 Table 145. Gubra In Vivo Pharmacology Product
 Table 146. Gubra Revenue in In Vivo Pharmacology Business (2020-2025) & (US$ Million)
 Table 147. Gubra Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. In Vivo Pharmacology Picture
 Figure 2. Global In Vivo Pharmacology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global In Vivo Pharmacology Market Share by Type: 2024 VS 2031
 Figure 4. Animal Disease Models Features
 Figure 5. Ex Vivo Pharmacology & Biomarkers Features
 Figure 6. PD/PK Features
 Figure 7. Others Features
 Figure 8. Global In Vivo Pharmacology Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global In Vivo Pharmacology Market Share by Application: 2024 VS 2031
 Figure 10. Ncology/Immuno-oncology Case Studies
 Figure 11. Metabolic Disorders Case Studies
 Figure 12. Inflammatory Diseases Case Studies
 Figure 13. CNS Diseases Case Studies
 Figure 14. In Vivo Pharmacology Report Years Considered
 Figure 15. Global In Vivo Pharmacology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global In Vivo Pharmacology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global In Vivo Pharmacology Market Share by Region: 2024 VS 2031
 Figure 18. Global In Vivo Pharmacology Market Share by Players in 2024
 Figure 19. Global Top In Vivo Pharmacology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Pharmacology as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by In Vivo Pharmacology Revenue in 2024
 Figure 21. North America In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America In Vivo Pharmacology Market Share by Country (2020-2031)
 Figure 23. United States In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe In Vivo Pharmacology Market Share by Country (2020-2031)
 Figure 27. Germany In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific In Vivo Pharmacology Market Share by Region (2020-2031)
 Figure 35. China In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America In Vivo Pharmacology Market Share by Country (2020-2031)
 Figure 43. Mexico In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa In Vivo Pharmacology Market Share by Country (2020-2031)
 Figure 47. Turkey In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE In Vivo Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Charles River Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 51. The Jackson Laboratory Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 52. Syngene Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 53. Evotec Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 54. Pharmaron Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 55. Aurigene Pharmaceutical Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 56. Jubilant Biosys Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 57. Labcorp Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 58. Inotiv Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 59. Takeda Pharmaceutical Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 60. EXUMA Biotech Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 61. Novartis Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 62. Be Biopharma Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 63. Alderley Oncology Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 64. Sygnature Discovery Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 65. GenScript ProBio Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 66. Zai Lab Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 67. Sinclair Research Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 68. Eli Lilly Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 69. Gubra Revenue Growth Rate in In Vivo Pharmacology Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions